News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
About the Author - Alex Keown

BioSpace News - By Alex Keown
Nestle's Galderma Laboratories to Slash Up to 450 Jobs at R&D Center 9/21/2017
Famed Genomics Pioneer's Synthetic Genomics Hit With Gender Discrimination Lawsuit by Former VP 9/21/2017
Rodin Nabs $27 Million to Carry HDAC Complex Compound into the Clinic 9/21/2017
Once-Prominent Bay Area Biotech VC, Steven Burrill, Faces Up to 30 Years in Prison 9/21/2017
Alnylam (ALNY) Stock Catapults as Genetic Disease Drug Meets All Phase III Goals 9/20/2017
Roche (RHHBY) Slammed With Partial Holds for Two Combo Cancer Trials 9/20/2017
Eli Lilly (LLY) Heads to Finish Line with Breast Cancer Treatment Abemaciclib 9/20/2017
Tiny Massachusetts Biotech Corbus (CRBP) to Triple HQ Space to Accommodate Growth 9/20/2017
Why Exiting the Generics Biz or a Break Up Could Save Troubled Teva (TEVA) 9/20/2017
How Gilead (GILD)'s $12 Billion Kite Pharma (KITE) Deal Has Already Paid Off for Investors 9/20/2017
Growing Catalent (CTLT) Takes Out Cook Pharmica in $950 Million Deal 9/20/2017
Booming Rho to Go on 40-Person+ Hiring Binge 9/20/2017
Johnson & Johnson (JNJ)-Backed Science Project to Create Champions of Science, Challenge Stereotypes 9/19/2017
Nabriva (NBRV)'s Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials 9/19/2017
Bay Area's Ultragenyx (RARE) Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics (DMTX) 9/19/2017
Massachusetts' Flexion (FLXN) Terminates R&D Deal With AstraZeneca PLC (AZN) 9/18/2017
Debt-Ridden Teva (TEVA) Gets Ready to Unload Another Asset Worth $800 Million 9/15/2017
Bavarian Nordic (BAVA.CO) Plummets 49% After Cancer Vaccine Flunks Late-Stage Test 9/15/2017
14 Women Land Board Positions Through Women in Bio, LifeSci Initiatives 9/15/2017
FDA Calls Regeneron (REGN), Sanofi (SNY) Carcinoma Drug a Breakthrough 9/15/2017
Pharma Bro Shkreli Gets Locked Up Over Bizarre Facebook Stunt 9/14/2017
AstraZeneca PLC (AZN) Offloads Remaining Anesthetics Portfolio in $766 Million Deal 9/14/2017
Through M&A, These 2 Biotechs Could Help a Refreshed Alexion (ALXN) Build Its Pipeline 9/14/2017
Amicus (FOLD) Dumps Lead Rare Disease Drug After Phase III Trial Failure 9/14/2017
Vertex (VRTX)’s Terminated Phase II CF Trial Was Planned 9/13/2017
LakePharma Opens New Facility in Bay Area's 'Birthplace of Biotechnology' 9/13/2017
SAGE Therapeutics (SAGE) Crashes Hard as Lead Epilepsy Drug Flunks Phase III Test 9/13/2017
Onxeo (ONXEO.PA) Plunges After Liver Cancer Drug Fails Late-Stage Study 9/12/2017
Gecko Biomedical is Expanding Following Marketing Approval of its Vascular Sealant 9/12/2017
The Search is Over: Struggling Teva (TEVA) Finally Gets a New CEO 9/11/2017
Unknown Number of Employees Impacted as ESSA Pharma Restructures and Refocuses R&D 9/11/2017
Massachusetts' Replimune Lands $55 Million, Taps Cancer Pioneer as CMO 9/8/2017
134 Employees Impacted as Elanco Consolidates 9/8/2017
Merck & Co. (MRK) Takes Out Immuno-Oncology Startup in $603 Million Deal 9/8/2017
After a Billion+ Loss to Alzheimer's at Medivation (MDVN), Hung Takes Another Shot at Ramaswamy's Axovant (AXON) 9/8/2017
Google (GOOG) Gets in on Bay Area Gritstone Oncology's $92.7 Million Series B Boost 9/8/2017
FDA Berates Pfizer (PFE) Unit for EpiPen Misfires During 'Life-Threatening Emergencies' 9/8/2017
Hiring Now: Dow Development Laboratories Takes More Space in the Bay Area 9/7/2017
Verastem (VSTM) Soars as Blood Cancer Drug Succeeds in Phase III Study 9/7/2017
Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen (BIIB) Spinoff Bioverativ (BIVV) 9/7/2017
Troubling Times for Shire (SHPG) as Execs Jump Ship and Employee Satisfaction is at an All Time Low 9/6/2017
Insmed (INSM) Rockets as Lung Drug Wows in Late-Stage Study 9/6/2017
Many Employees Moved to Boston as Part of Takeda (TKPYY)'s Transformation 9/5/2017
Meet the Stanford and USC Dropouts Whose Blood-Testing Startup 'Isn't the Next Theranos' 9/5/2017
SoCal's Cytori (CYTX) Pink Slips 50% of Workforce in Restructuring 9/5/2017
Johnson & Johnson (JNJ) Dissolves $700 Million R&D Deal With MacroGenics (MGNX) 9/5/2017
Novartis AG (NVS) Waltzes to the Finish Line With First Ever FDA Approval for CAR-T 9/1/2017
Former Celator (CPXX) CPA Connived With Two Friends, Father on Insider-Trading Scheme 9/1/2017
Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma 9/1/2017
Cambrex Corporation (CBM) to Hire a Dozen New R&D Scientists in Expansion 8/31/2017
Five Prime (FPRX) Terminates $460 Million Immuno-oncology Deal With This SoCal Biotech 8/31/2017
Integral Molecular Doubles Employee Headcount in Facility Expansion 8/31/2017
Allergan (AGN) is Laying Off 109 Employees in SoCal, Effective October 23 8/31/2017
Otonomy (OTIC) Suspends Development of Lead Drug After Phase III Flop, Stock Plunges 8/31/2017
Royal Philips Electronics N.V. (PHG) to Bring 800 New Jobs to Nashville 8/30/2017
Jazz Pharma (JAZZ) Bets $175 Million on This Massachusetts Biotech's Antibody-Drug Program 8/29/2017
InVivo Therapeutics (NVIV) Slashes 39% of Jobs and Cuts Two R&D Programs in Restructuring 8/29/2017
A First: Novartis AG (NVS) Drug May Prevent Heart Attacks and Cut Lung Cancer Risk Too 8/29/2017
Gilead (GILD) Goes Big, Pays $11.9 Billion for This SoCal CAR-T Biopharma 8/28/2017
Big-Name Investor Peter Thiel Funds ‘Unethical’ Offshore Herpes Vaccine Trial 8/28/2017
The FDA Calls Kyowa Hakko's Lymphoma Drug a Breakthrough 8/25/2017
Troubled Dimension Therapeutics (DMTX) Sold in All-Stock Deal 8/25/2017
Former Schering-Plough (SGP) CEO Says This is the 'Worst Solution' to the Drug Pricing Dilemma 8/25/2017
Massachusetts Startup sRNAlytics Develops Potent Small RNA Biomarker Sequencing Data 8/25/2017
2 Biotechs Billionaires are Loading Up on in 2017 8/24/2017
Boston's Paratek (PRTK) Heads to The Auction Block 8/24/2017
This Pharma Giant Doesn't Want Its Drug Used in Death Penalty Executions 8/24/2017
Job Cuts and Facility Reductions Loom Over SoCal's ImmunoCellular (IMUC) 8/24/2017
Seattle's Omeros (OMER) Fires Back But Still Won't Answer Basic Questions About Key Drug 8/24/2017
How Roche (RHHBY) Fine-Tuned an Old Drug Under a New Name to Keep Making Profits 8/24/2017
Shire (SHPG) CFO Quits for Boston-Based Microbiome Startup 8/22/2017
Gene Therapy Firm Krystal Biotech Files for $35 Million IPO 8/22/2017
Look Out Biotechs, Ambitious Plans Emerge for New York’s Next Life Science Center 8/22/2017
Biosimilars Giant Takes the Plunge Into Original Biotech Drugs Via Takeda (TKPYY) Deal 8/21/2017
Biotech Startups Flock to the Suburbs Over Rising Rent Prices 8/21/2017
AstraZeneca PLC (AZN) Jumps Deeper Into mRNA Drugs With Ethris Deal 8/21/2017
Heads Up Tesaro (TSRO): AstraZeneca PLC (AZN), Merck & Co. (MRK)'s Ovarian Cancer Drug Just Got Expanded Use From the FDA 8/18/2017
FDA Green Lights Pfizer (PFE) Drug for Rare, Fast-Killing Type of Leukemia 8/18/2017
LifeNet to Create Hundred of New Jobs in Virginia Through HQ Expansion 8/18/2017
This is What Happens When the FDA Approves Cancer Drugs Too Quickly 8/17/2017
Johnson & Johnson (JNJ) CEO Backpedals and Quits Right Before Trump Disbands Council 8/17/2017
Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+ 8/17/2017
How Eli Lilly (LLY) Allegedly Used a Fake Rule and Fake News to Protect Bad Patents 8/16/2017
Jounce (JNCE) Names Ex-Ariad (ARIA)'s Top Dealmaker as Its New CBO 8/16/2017
Struggling Teva (TEVA) Seeks Partners to Fund Some Projects in Its Drug Pipeline 8/16/2017
What You Need to Know About Merck & Co. (MRK)'s Fearless CEO Ken Frazier 8/15/2017
Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma 8/15/2017
Merck & Co. (MRK) CEO Resigns From President Trump's American Manufacturing Council by Tweet 8/15/2017
As Its CEO Retires, Cerecor (CERC) Divests Depression Drug to Pharma Giant in $45 Million Deal 8/15/2017
Vicarius Pharma Launches With $21.8 Million and Will be Helmed by Former Biogen (BIIB)-Elan (ELN) Exec 8/15/2017
Biotech Startup Prelude Therapeutics Gets Grant to Triple Its Workforce 8/15/2017
Galapagos (GLPG.BR)' Phase II Results With GLPG1690 are 'Extremely Exciting' 8/14/2017
Zeria Pharmaceutical Employee's Death Was 'Job-Related' 8/14/2017
Biogen (BIIB) Quietly Registered Biogen Korea in South Korea Last Month 8/14/2017
Perrigo (PRGO) Unveils Sale of Two Business Units 8/14/2017
Takeda (TKPYY) Teams Up With Marvel Comics on Inflammatory Bowel Disease Graphic Novel 8/11/2017
Peregrine (PPHM) Slashes Workforce by 20% in Cost Cutting Plan 8/11/2017
Gilead (GILD)'s HIV Triple Combo Gets Sped-up FDA Review, Decision Date Locked Down 8/11/2017
Pharma Bro Martin Shkreli's New Startup Is Hiring 8/11/2017
Former PTC Therapeutics (PTCT) Exec Jumps Ship to Orchard Therapeutics as CEO 8/11/2017
World's Largest Generic Drugmaker Teva (TEVA) Looks to Sell Medis Business 8/11/2017
Race Heats Up As Mallinckrodt (MNK) Gets Bids 8/10/2017
San Diego-based Biotech Expands for Future Growth and Top Talent 8/9/2017
Cempra (CEMP) Seals Merger Deal With This Antibiotics Biopharmaceutical 8/9/2017
Bay Area Galena Biopharma  (GALE) Merges With Oncology-Focused Biopharma in All-Stock Deal 8/9/2017
Startup MyndYou Using AI to Treat Alzheimer’s Disease 8/9/2017
Esperion (ESPR) Stock Gains On Strong Phase II Data 8/8/2017
Notorious 'Pharma Bro' Martin Shkreli Found Guilty, Faces Up to 20 Years in Prison 8/8/2017
Aclaris (ACRS) Scoops Up St. Louis Startup in Deal Worth Up to $100M 8/8/2017
New CEO Takes Over Rapamycin, Leads Funding Round With Plans for IND 8/8/2017
Teva (TEVA) to Cut 7,000 Jobs, Halt Operations in 45 Countries 8/8/2017
Pharma Scores Big Win: Trump to Ink FDA User Fee Bill, Saving 5,000 Jobs 8/7/2017
AbbVie (ABBV) Wins FDA Approval for the First-Ever Drug to Treat All Forms of Hep C 8/7/2017
Mallinckrodt (MNK) to Snap Up Pennsylvania Drugmaker For Up to $425M 8/7/2017
Gemphire Shares Drop on Disappointing Phase II Results for LDL Drug 8/7/2017
Former Google (GOOG) Exec Steps Down as GRAIL CEO 8/4/2017
FDA Advisory Panel Votes Against Approval Of Johnson & Johnson (JNJ)’s Sirukumab 8/4/2017
Ocular Therapeutix (OCUL) to Slash Jobs After FDA Rejection 8/4/2017
QPS Holdings to Double Workforce in Expansion 8/4/2017
Former Biotech CEO Accused of Defrauding Investors 8/3/2017
4 Clinical Projects Shelved From Pfizer (PFE)’s Pipeline 8/3/2017
Pharma Giant AstraZeneca PLC (AZN) Scores Another FDA Breakthrough 8/3/2017
FDA Calls AstraZeneca PLC (AZN) and MedImmune (AZN)’s Imfinzi a Breakthrough 8/2/2017
8 PDUFA Dates to Watch in August 8/2/2017
PixarBio Slashed Headcount, Evicted from Medford Headquarters 8/2/2017
AstraZeneca PLC (AZN) Seen as “Tricky” Takeover Target After Big Setback Last Week 8/2/2017
Following Recent Death, InVivo Therapeutics (NVIV) Temporarily Halts Enrollment in INSPIRE Study 8/2/2017
FDA Raises Big Safety Concerns With Johnson & Johnson (JNJ)'s Arthritis Drug Sirukumab 8/1/2017
Milestone Pharma Banks $55M, Advances Etripamil into Phase III and Expands Headcount 8/1/2017
Mankind Pharma’s Subsidiary Lifestar Pharma Expands R&D in RTP Hub 8/1/2017
Bristol-Myers Squibb (BMY), Clovis Oncology (CLVS) Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III 8/1/2017
FDA Calls Roche (RHHBY)'s Leukemia Drug a Breakthrough 7/31/2017
Why AstraZeneca PLC (AZN)'s MYSTIC Trial Failure May be a Bad Sign for Bristol-Myers Squibb (BMY) 7/31/2017
AstraZeneca PLC (AZN) Seals a $8.5 Billion R&D Cancer Tie-Up With Merck & Co. (MRK) 7/28/2017
AstraZeneca PLC (AZN) Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints 7/28/2017
Boston Scientific (BSX) Warns of Fluke Death Involving Its S-ICD Pacemaker 7/28/2017
FDA Head Postpones Layoff Notices of Thousands of Employees 7/28/2017
Not-Yet Sold Tesaro (TSRO) Bags $340 Million Cancer Deal With Pharma Giant Takeda (TKPYY) 7/28/2017
Death Count Rises for Patients on Dynavax (DVAX)'s Hep B Vaccine But Overall Rate Was Low, Says the FDA 7/27/2017
Heads Up Startups: Silicon Valley VC Firm—With an Appetite for Biotech—Nabs Record $800 Million Fund 7/26/2017
Merck & Co. (MRK) Plans to File NDA for HIV Treatment Doravirine Based on Phase III Results 7/26/2017
2 Tiny Cancer Biotechs That Could Gain Steam by Year-End 7/26/2017
Merck & Co. (MRK) Dealt Another Setback as Its Ace Keytruda Comes Up Short in Head and Neck Cancer Study 7/26/2017
Japanese Pharma Giant Astellas (ALPMY) Sets Up Shop in Cambridge 7/25/2017
Blood Clot Fears Delay Eli Lilly (LLY), Incyte (INCY)'s Potential Rheumatoid Arthritis Blockbuster, Stocks Fall 7/25/2017
Mitsubishi Tanabe Coughs Up $1.1 Billion Cash for This Parkinson's Biotech 7/25/2017
Teva (TEVA) to Slash Up to 350 Employees in Reorg 7/25/2017
Massachusetts’ Histogenics Looks to NeoCart for Replacing Knee Cartilage Loss 7/25/2017
Bay Area's Nektar (NKTR) Inks $400 Million+ Autoimmune Disease Pact With Eli Lilly (LLY) 7/25/2017
Texas Officials Lure Life Sciences Companies Like Merck & Co. (MRK), Which is Expected to Employ 600 7/25/2017
AstraZeneca PLC (AZN) CEO Breaks Silence on Teva (TEVA) Rumors, Urges Staff to Remain Focused in Leaked Memo 7/24/2017
Bay Area Nektar (NKTR)' Comeback is Stalled as the EMA Rejects Breast Cancer Drug 7/21/2017
Endo International (ENDP) Slashes 875 Jobs and Will Shutter Alabama Facilities 7/21/2017
New Braeburn Pharma CEO Has Company on Track with Filing for Opioid Addiction Drug NDA 7/21/2017
Roche (RHHBY) Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics 7/21/2017
Ironwood (IRWD)'s Potential Blockbuster Drug Meets Main Goals in Mid-Stage Trial 7/21/2017
Vertex (VRTX) Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials 7/21/2017
Ablynx (ABLYF) Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi (SNY) 7/21/2017
FDA Green Lights Gilead (GILD)'s Vosevi, With a Black Box Warning Attached 7/20/2017
Puma Biotech (PBYI) Surges After the FDA Officially Approves Breast Cancer Drug 7/19/2017
Siemens Breaks Ground on $300 Million Expansion in Walpole, Mass., Plans for 700 New Jobs 7/19/2017
How AstraZeneca PLC (AZN)'s Silence Led to a $4 Billion Loss Overnight 7/19/2017
Another Alzheimer's Let-Down as FUJIFILM's Candidate Flunks Phase II Test 7/19/2017
The Quest of the Ambitious New Generation of Family-Run Boehringer Ingelheim 7/18/2017
CDMO Alcami to Move HQ to RTP, New Jobs Expected 7/18/2017
AstraZeneca PLC (AZN) Confirms CEO is Staying Put—For Now 7/18/2017
Radius Health (RDUS)'s Longtime CEO Out, Former Novo Nordisk A/S (NVO) Exec Named New Leader 7/18/2017
Gottlieb Lays Out Plans to Attract and Preserve Top Talent at the FDA 7/18/2017
Teva (TEVA) Accuses Former Top Exec of Passing on Trade Secrets to Boyfriend—CEO of Rival Apotex 7/17/2017
Sources Reveal Tesaro (TSRO) is Unlikely to Find a Buyer 7/17/2017
Bay Area's Booming CS Bio Submits Plans for New Complex to Triple the Size of Its Workforce 7/17/2017
Rumor Alert: AstraZeneca PLC (AZN) CEO to Become Teva (TEVA)'s New Leader 7/14/2017
Merck KGaA (MKGAF.PK) to Shutter Four Sites, Lay Off 200 Employees 7/14/2017
Cash-Strapped Alder Biopharma (ALDR) Secures $160 Million in Stock Sale to Continue Operations 7/14/2017
Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's 7/13/2017
5 Drug Stocks That Could be Big Winners in Q2 Earnings 7/13/2017
Cost-Cutting Continues as AstraZeneca PLC (AZN) Unloads U.S. HQ in $50 Million Deal 7/13/2017
Two Bay Area Diagnostic Companies Win Amgen (AMGN)'s Golden Ticket 7/12/2017
Backed by Google (GOOG), Evelo Bags $50 Million and Names Some Industry Vets to the Team 7/12/2017
Bay Area's OncoMed (OMED) Tanks Some More as GlaxoSmithKline (GSK) Walks Away From R&D Pact 7/12/2017
'Retired' Celgene (CELG) Alum Lands Chairman Gig at Biotech Guru Ramaswamy's Dermavant 7/11/2017
Groundbreaking: Amicus (FOLD) Surges as the FDA Changes Its Tune on Fabry Disease Drug 7/11/2017
Neothetics (NEOT) to Slash an Unknown Number of Jobs, Review Strategic Alternatives 7/11/2017
Production Problems Lead Pacira (PCRX) to Cut Jobs in San Diego 7/11/2017
Waiting Lists are Already Forming for Novartis AG (NVS) and Kite Pharma (KITE)'s Not-Yet Approved CAR-T Drugs 7/11/2017
Booming Jazz Pharma (JAZZ) Inks Huge Lease in Philadelphia to Accomodate Growth 7/10/2017
Alexion (ALXN) is Under Investigation by the HHS Office of Inspector General 7/10/2017
3 Biotechs That Could be Sweet M&A Targets for Big Pharma 7/7/2017
Bay Area's Biggest Startup Factory Looks to Fund This New Type of Biotech 7/7/2017
Patient Deaths Prompt the FDA to Suspend Three of Merck & Co. (MRK)'s Keytruda Trials 7/7/2017
Court Papers Reveal AstraZeneca PLC (AZN) CEO Was Livid Over Protege's Defection to GlaxoSmithKline (GSK) 7/6/2017
Interleukin Genetics (ILGN) Slashes 63% of Workforce, Shuts Down Program and Mulls Sale 7/6/2017
Why Theranos Could Burn Through All Its Cash by the End of This Year 7/5/2017
The 2 Biotechs That Turned $8,000 Into at Least $25,600 in Just One Year 7/5/2017
This New Jersey Biotech is Set to Grow EPS by 39,100% Through 2020 7/5/2017
Struggling MannKind (MNKD) Hires Financial Advisor After Maxing Out Its Last Credit Line 6/30/2017
BIO2017: Companies Highlight Numerous Innovations During San Diego Convention 6/27/2017
FDA Calls Cara Therapeutics (CARA)' Kidney Disease Drug a Breakthrough, Stock Soars 6/26/2017
bluebird bio (BLUE) Touts Impressive Data From Late-Stage Gene Therapy Study 6/26/2017
Employee in Critical Condition After Shooting at San Diego Biotech Phamatech 6/23/2017